$GERN News

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron To Present Real-World Moffitt Cancer Center Study Showing RYTELO (imetelstat) Safety And Efficacy In Lower-Risk MDS At EHA 2026

Geron Corporation (GERN) Q1 2026 Earnings Call Transcript

Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues

Geron Reports Q1 2026 Results: Full Earnings Call Transcript

Geron Q1 EPS $(0.01) Beats $(0.02) Estimate, Sales $51.771M Beat $50.582M Estimate

Geron: Minimal Sales Growth But A Potential Run-Up Ahead

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Details RYTELO Growth Plan, $220M-$240M 2026 Sales Guide and MF Trial Catalyst at Barclays Conference

Geron Corporation (GERN) Reports Q4 EPS of (5c)

How The Geron (GERN) Story Is Shifting After Target Cut And New Equity Plans

Is Geron (GERN) Using Its New ATM Program To Prioritize Flexibility Over Shareholder Dilution?

Geron Files Prospectus For Offering Mixed Shelf; Terms Not Disclosed

Geron (GERN) 2025 Revenue Surges to $183.6M Driven by RYTELO Commercial Success

Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings

Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments

Geron Corporation Q4 2025 Earnings Call Summary

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates

Geron Q4 Earnings Call Highlights

Geron Corp (NASDAQ:GERN) Stock Plummets 10% After Q4 Revenue Miss